JACKSON, Miss. — The FDA has approved Yeztugo, the world’s first twice-a-year shot to prevent HIV infection, marking a significant advancement in HIV prevention. The new treatment is expected to be a ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more t… ...

Globally, Montaner said, it is estimated American funding cuts will lead to another 6.6 million new HIV infections and an additional 4.2 million AIDS-related deaths between 2025 and 2029.

With a 500-percent surge in new human immunodeficiency virus or HIV cases per day, the Philippines now has the fastest-growing number of people living with HIV (PLHIV) in the Western Pacific region.

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

The first cases of HIV in the U.S. were reported on June 5, 1981. HIV is a virus that attacks a person's immune system, making them vulnerable to disease.